MS Wonder Drug Questioned Before Approval

When I shared the news with you that Tysabri -- that so-called "wonder drug" for multiple sclerosis (MS) -- had been pulled from the market Monday by Biogen Idec and Elan Corp., I suspected there was more to the story than was being first reported. Particularly when a patient dies unexpectedly of a rare disease like progressive multifocal leukoencephalopathy (PML), a central nervous system disease usually seen in AIDS patients. There were certainly enough warnings about Tysabri. One...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports